A nanoparticulate system that enhances the efficacy of the tumoricide Dz13 when administered proximal to the lesion site

Journal of Controlled Release

Volumn 144, Issue 2, 2010, Pages 196-202

  Tan, Mei Lin ^a,b   Dunstan, Dave E ^b   Friedhuber, Anna M ^b   Choong, Peter F M ^a,b,c   Dass, Crispin R ^a  

^a ST VINCENT S HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

Antisense; Cancer; Chitosan; DNAzyme; Nanoparticle; Tumour

Indexed keywords

ANTISENSE; CANCER CELL GROWTH; CANCER CELLS; CHITOSAN CONCENTRATION; CHITOSAN NANOPARTICLES; DISEASE MODELS; DNAZYME; HUMAN SERUM; IN-VITRO; IN-VIVO; LESION SITE; NANOPARTICULATE SYSTEM; OPTIMISATIONS; OSTEOSARCOMA; SIDE EFFECT;

BONE; CELLS; CHITOSAN; GROWTH KINETICS; NANOPARTICLES; TUMORS;

CHITIN;

CHITOSAN; DEOXYRIBOZYME; DZ13; NANOPARTICLE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER INHIBITION; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION; DRUG STABILITY; DRUG STORAGE; ENCAPSULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUSE; NONHUMAN; OSTEOSARCOMA; OSTEOSARCOMA CELL; PH; PRIORITY JOURNAL; TEMPERATURE;

ANIMALS; BONE NEOPLASMS; CHITOSAN; DNA; HUMANS; MICE; MICE, INBRED BALB C; MICE, NUDE; NANOPARTICLES; OSTEOSARCOMA;

EID: 77952670773     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2010.01.011     Document Type: Article

References (26)

1. Khachigian L.M., Fahmy R.G., Zhang G., Bobryshev Y.V., Kaniaros A. c-Jun regulates vascular smooth muscle cell growth and neointima formation after arterial injury. Inhibition by a novel DNA enzyme targeting c-Jun. J. Biol. Chem. 2002, 277:22985-22991.
2. Zhang G., Dass C.R., Sumithran E., Di Girolamo N., Sun L.-Q., Khachigian L.M. Effect of deoxyribozymes targeting c-Jun on solid tumor growth and angiogenesis in rodents. J. Natl. Cancer Inst. 2004, 96:683-696.
3. Zhang G., Luo X., Sumithran E., Pua V.S., Barnetson R.S., Halliday G.M., Khachigian L.M. Squamous cell carcinoma growth in mice and in culture is regulated by c-Jun and its control of matrix metalloproteinase-2 and -9 expression. Oncogene 2006, 25:7260-7266.
4. Dass C.R., Friedhuber A.M., Khachigian L.M., Dunstan D.E., Choong P.F.M. Downregulation of c-jun results in apoptosis-mediated anti-osteosarcoma activity in an orthotopic model. Cancer Biol. Ther. 2008, 7:1033-1036.
5. Dass C.R., Khachigian L.M., Choong P.F. c-Jun Is critical for the progression of osteosarcoma: proof in an orthotopic spontaneously metastasizing model. Mol. Cancer Res. 2008, 6:1289-1292.
6. Dass C.R., Khachigian L.M., Choong P.F.M. c-Jun knockdown sensitizes osteosarcoma to doxorubicin. Mol. Cancer Ther. 2008, 7:1909-1912.
7. Dass C.R., Galloway S.J., Clark J.C., Khachigian L.M., Choong P.F.M. Involvement of c-jun in human liposarcoma growth: supporting data from clinical immunohistochemistry and DNAzyme efficacy. Cancer Biol. Ther. 2008, 7:1297-1301.
8. Dass C.R., Friedhuber A.M., Khachigian L.M., Dunstan D.E., Choong P.F.M. Biocompatible chitosan-DNAzyme nanoparticle exhibits enhanced biological activity. J. Microencapsul. 2008, 25:421-425.
9. Habraken W.J., Wolke J.G., Jansen J.A. Ceramic composites as matrices and scaffolds for drug delivery in tissue engineering. Adv. Drug Deliv. Rev. 2007, 59:234-248.
10. Leong K.W., Mao H.Q., Truong-Le V.L., Roy K., Walsh S.M., August J.T. DNA-polycation nanospheres as non-viral gene delivery vehicles. J. Control. Release 1998, 53:183-193.
11. Dass C.R., Contreras K.G., Dunstan D.E., Choong P.F. Chitosan microparticles encapsulating PEDF plasmid demonstrate efficacy in an orthotopic metastatic model of osteosarcoma. Biomaterials 2007, 28:3026-3033.
12. Ta H.T., Dass C.R., Larson I., Choong P.F., Dunstan D.E. A chitosan hydrogel delivery system for osteosarcoma gene therapy with pigment epithelium-derived factor combined with chemotherapy. Biomaterials 2009, 30:4815-4823.
13. Dass C.R., Saravolac E.G., Li Y., Sun L.-Q. Cellular uptake, distribution and stability of 10-23 deoxyribozymes. Antisense Nucleic Acid Drug Dev. 2002, 2:289-299.
14. Ek E.T., Dass C.R., Contreras K.G., Choong P.F. Inhibition of orthotopic osteosarcoma growth and metastasis by multitargeted antitumor activities of pigment epithelium-derived factor. Clin. Exp. Metastasis 2007, 24:93-106.
15. Dass C.R., Ek E.T., Contreras K.G., Choong P.F. A novel orthotopic murine model provides insights into cellular and molecular characteristics contributing to human osteosarcoma. Clin. Exp. Metastasis 2006, 23:367-380.
16. Fahmy R.G., Dass C.R., Sun L.-Q., Chesterman C.N., Khachigian L.M. Early Growth Response factor-1: a key mediator of tumour angiogenesis and neovascularisation. Nat Med 2003, 9:1026-1032.
17. Mitchell A., Dass C.R., Sun L.Q., Khachigian L.M. Inhibition of human breast carcinoma proliferation, migration, chemoinvasion and solid tumour growth by DNAzymes targeting the zinc finger transcription factor EGR-1. Nucleic Acids Res. 2004, 32:3065-3069.
18. Tinari A., Giammarioli A.M., Manganelli V., Ciarlo L., Malorni W. Analyzing morphological and ultrastructural features in cell death. Methods Enzymol. 2008, 442:1-26.
19. Tan M.L., Choong P.F., Dass C.R. Cancer, chitosan nanoparticles and catalytic nucleic acids. J. Pharm. Pharmacol. 2009, 61:3-12.
20. Boynueǧri D., Ozcan G., Senel S., Uç D., Uraz A., Oǧüş E., Cakilci B., Karaduman B. Clinical and radiographic evaluations of chitosan gel in periodontal intraosseous defects: a pilot study. J. Biomed. Mater. Res. B Appl. Biomater. 2009, 90:461-466.
21. Ta H.T., Dass C.R., Larson I., Choong P.F., Dunstan D.E. A chitosan-dipotassium orthophosphate hydrogel for the delivery of doxorubicin in the treatment of osteosarcoma. Biomaterials 2009, 30:3605-3613.
22. Tan M.L., Friedhuber A.M., Dunstan D.E., Choong P.F., Dass C.R. The performance of doxorubicin encapsulated in chitosan-dextran sulphate microparticles in an osteosarcoma model. Biomaterials 2010, 31:514-551.
23. Vila A., Sánchez A., Tobío M., Calvo P., Alonso M.J. Design of biodegradable particles for protein delivery. J. Control. Release 2002, 78:15-24.
24. Grenha A., Seijo B., Remuñán-López C. Microencapsulated chitosan nanoparticles for lung protein delivery. Eur. J. Pharm. Sci. 2005, 25:427-437.
25. Clark J.C., Dass C.R., Choong P.F. A review of clinical and molecular prognostic factors in osteosarcoma. J. Cancer Res. Clin. Oncol. 2008, 134:281-297.
26. Tan M.L., Choong P.F., Dass C.R. Osteosarcoma: conventional treatment vs. gene therapy. Cancer Biol. Ther. 2009, 8:106-117.